osteoarthritis susceptibility 1

Any osteoarthritis in which the cause of the disease is a mutation in the FRZB gene.


HYDROGEN SULFIDE

A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.


SELT_HUMAN Thioredoxin reductase-like selenoprotein T (sprot)

A thioredoxin reductase-like selenoprotein T that is encoded in the genome of human.


Selenocysteine

The L-enantiomer of selenocysteine.


Gulonic acid

A gulonic acid having D-configuration.


Phloretin

A member of the class of dihydrochalcones that is dihydrochalcone substituted by hydroxy groups at positions 4, 2', 4' and 6'.


Daidzein

A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4'.


Cyclohexanone

A cyclic ketone that consists of cyclohexane bearing a single oxo substituent.


Indole-3-carboxylic acid

An indole-3-carboxylic acid carrying a carboxy group at position 3.


cervical cancer

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:ThingWithTaxon

A primary or metastatic malignant neoplasm involving the cervix.


A methyladenosine carrying a methyl substituent at position 1.


Symmetric dimethylarginine

A  L-arginine derivative having two methyl groups at the N(omega)- and N'(omega)-positions


D-GLUTAMATE

An optically active form of glutamic acid having D-configuration.


Glycolaldehyde

The glycolaldehyde derived from ethylene glycol. The parent of the class of glycolaldehydes.


Grape sugar

D-Glucopyranose having alpha-configuration at the anomeric centre.


L-Dihydroorotic acid

The (S)-enantiomer of dihydroorotic acid that is an intermediate in the metabolism of pyridine.


GDP-glucose

A GDP-D-glucose having alpha-configuration at the anomeric centre.


TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 (sprot)

A transient receptor potential cation channel TRPA1 that is encoded in the genome of human.


l-Menthol

A p-menthan-3-ol which has (1R,2S,5R)-stereochemistry. It is the most common naturally occurring enantiomer.


5-Aminovaleric acid

A delta-amino acid comprising pentanoic acid with an amino substituent at C-5; a methylene homologue of gamma-aminobutyric acid (GABA) that is a weak GABA agonist.


DDB2_HUMAN DNA damage-binding protein 2 (sprot)

A DNA damage-binding protein 2 that is encoded in the genome of human.


DDB1_HUMAN DNA damage-binding protein 1 (sprot)

A DNA damage-binding protein 1 that is encoded in the genome of human.


PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 (sprot)

A poly(U)-binding-splicing factor PUF60 that is encoded in the genome of human.


Pyrimidine

The parent compound of the pyrimidines; a diazine having the two nitrogens at the 1- and 3-positions.


Q2VT96_HUMAN chitinase (Fragment) (trembl)


A5D6V7_HUMAN chitinase (Fragment) (trembl)


Q5VUV5_HUMAN chitinase (Fragment) (trembl)


Triacetylchitotriose

A linear amino trisaccharide consisting of three N-acetyl-beta-D-glucosamine residues linked (1->4).


alpha-D-GALACTURONIC ACID

The alpha-anomer of D-galacturonic acid.


The simplest member of the class of 1,4-benzoquinones, obtained by the formal oxidation of hydroquinone to the corresponding diketone. It is a metabolite of benzene.


Propionaldehyde

An aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals.


D-ornithine

The D-enantiomer of ornithine. It is an intermediate metabolite produced in the urea cycle.


Limonene, (+)-

An optically active form of limonene having (4R)-configuration.


EDN1_HUMAN Endothelin-1 (sprot)

An endothelin-1 that is encoded in the genome of human.


DYL1_HUMAN Dynein light chain 1, cytoplasmic (sprot)

A dynein light chain 1, cytoplasmic that is encoded in the genome of human.


Nitric Oxide

A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.


2-Phospho-D-Glyceric Acid

A 2-phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.


beta-D-Galactopyranuronic acid

A D-galactopyranuronic acid with a beta-configuration at the anomeric center.


D-Lysine

The D-enantiomer of the alpha-amino acid lysine.


D-serine

The R-enantiomer of serine.


An alpha-diketone that is butane substituted by oxo groups at positions 2 and 3. It is a metabolite produced during the malolactic fermentation.


D-proline

The D-enantiomer of proline.


D-Arginine

A D-alpha-amino acid that is the D-isomer of arginine.


D-glutamine

The D-enantiomer of glutamine.


Cetyl Alcohol

A long chain fatty alcohol that is hexadecane substituted by a hydroxy group at position 1.


cob(I)alamin

A cobalamin in which the central cobalt atom has an oxidation state of +1.


L-histidinol

An amino alcohol that is propanol substituted by 1H-imidazol-4-yl group at position 3 and an amino group at position 2 (the 2S stereoisomer).


Q53H18_HUMAN Beta-galactosidase (Fragment) (trembl)


Q53G40_HUMAN Beta-galactosidase (Fragment) (trembl)


beta-D-GALACTOPYRANOSE

A D-galactopyranose having beta-configuration at the anomeric centre.


4-Guanidinobutyric acid

The 4-guanidino derivative of butanoic acid.


L-Gulonolactone

The furanose form of gulonolactone having L-configuration.


A diiodotyrosine that is L-tyrosine carrying iodo-substituents at positions C-3 and C-5 of the benzyl group. It is an intermediate in the thyroid hormone synthesis.


beta-D-Glucose 6-phosphate

A D-glucopyranose 6-phosphate in which the anomeric centre has beta-configuration.


cis-Caffeic acid

The cis-isomer of caffeic acid.


FYTIC ACID

A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.


alpha-D-Glucose 1,6-bisphosphate

A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates.


3-Hydroxy-3-Carboxy-Adipic Acid

The (R)-enantiomer of homocitric acid.


A cholestanoid that is 5beta-cholestan-26-al substituted by hydroxy groups at positions 3, 7 and 12 respectively.


A deoxyinosine phosphate compound having a diphosphate group at the 5'-position.


2'-Deoxyinosine triphosphate

A deoxyinosine phosphate compound having a triphosphate group at the 5'-position.


3'-Adenylic acid

An adenosine 3'-phosphate with a monophosphate group at the 3'-position.


Butyraldehyde

A member of the class of  butanals that consists of propane bearing a formyl substituent at the 1-position. The parent of the class of butanals.


Calcifediol

A hydroxycalciol that is calciol in which the hydrogen at position 25 has been replaced by a hydroxy group. A prehormone resulting from the oxidation of calciol in the liver, it is further hydroxylated in the kidney to give calcitriol, the active form of vitamin D3.


Stachyose

A tetrasaccharide consisting of sucrose having an alpha-D-galactosyl-(1->6)-alpha-D-galactosyl moiety attached at the 6-position of the glucose.


Phytonadione

A member of the class of phylloquinones that consists of 1,4-naphthoquinone having methyl and phytyl groups at positions 2 and 3 respectively. The parent of the class of phylloquinones.


Lauroyl-coa

A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of lauric (dodecanoic) acid.


SCOPOLAMINE

A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol.


pseudotumor cerebri

Idiopathic intracranial hypertension is a neurological disorder characterized by isolated increased intracranial pressure manifesting with recurrent and persistent headaches, nausea, vomiting, progressive and transient obstruction of the visual field, papilledema. Visual loss can be irreversible.


Dehydroalanine

A 2,3-dehydroamino acid that is alanine which has been dehydrogenated to introduce a double bond between positions 2 and 3.


Perillyl alcohol

A limonene monoterpenoid consists of a cyclohexene ring substituted by a hydroxymethyl  and a prop-1-en-2-yl group at positions 1 and 4 respectively. It is a constituent of a variety of essential oils including lavender.


MT1E_HUMAN Metallothionein-1E (sprot)

A metallothionein-1E that is encoded in the genome of human.


MT1F_HUMAN Metallothionein-1F (sprot)

A metallothionein-1F that is encoded in the genome of human.


MT1G_HUMAN Metallothionein-1G (sprot)

A metallothionein-1G that is encoded in the genome of human.


MT1H_HUMAN Metallothionein-1H (sprot)

A metallothionein-1H that is encoded in the genome of human.


MT1X_HUMAN Metallothionein-1X (sprot)

A metallothionein-1X that is encoded in the genome of human.


MT1L_HUMAN Metallothionein-1L (sprot)

A metallothionein-1L that is encoded in the genome of human.


MT1M_HUMAN Metallothionein-1M (sprot)

A metallothionein-1M that is encoded in the genome of human.


MT1A_HUMAN Metallothionein-1A (sprot)

A metallothionein-1A that is encoded in the genome of human.


MT1B_HUMAN Metallothionein-1B (sprot)

A metallothionein-1B that is encoded in the genome of human.


A imidazolidine-2,4-dione that is the N-methyl-derivative of hydantoin.


Perillaldehyde

An aldehyde that is cyclohex-1-ene-1-carbaldehyde substituted by a prop-1-en-2-yl group at position 4.


Vitamin A palmitate

An all-trans-retinyl ester obtained by formal condensation of the carboxy group of palmitic (hexadecanoic acid) with the hydroxy group of all-trans-retinol. It is used in cosmetic products to treat various skin disorders such as acne, skin aging, wrinkles, dark spots, and also protect against psoriasis.


p-Coumaryl alcohol

4-Hydroxycinnamyl alcohol with E-configuration of the propenyl double bond. It is one of the main monolignols.


N-Methylputrescine

An N-monosubstituted putrescine where the N-substituent is methyl.


phosphoribosyl-ATP

A 1-(5-phospho-D-ribosyl)-ATP in which the 5-phospho-D-ribosyl residue has beta-configuration at the anomeric centre.


A dialkyl ketone with methyl and pentyl as the alkyl groups.


4-Acetamidobutyric acid

An N-acyl-gamma-aminobutyric acid resulting from the monoacetylation of the nitrogen of GABA.


A dimethylbenzimidazole carrying methyl substituents at positions 5 and 6.


Resveratrol

A resveratrol in which the double bond has E configuration.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as capryl (decanoyl).


A C21-steroid hormone that is 5alpha-pregnane substituted by oxo groups at positions 3 and 20. It is a metabolite of progestrone.


Etiocholanedione

An androstane-3,17-dione with a 5beta-configuration.


A phenylacetaldehyde in which the 3 and 4 positions of the phenyl group are substituted by hydroxy groups.


Androstenediol

A 3beta-hydroxy-Delta(5)-steroid that is 3beta-hydroxyandrost-5-ene carrying an additional hydroxy group at position 17beta.


Cholesteryl acetate

A cholesterol ester obtained by formal acylation of the hydroxy group of cholesterol by acetic acid.


The pteridine that is lumazine substituted with methyl groups at C-6 and -7 and with a 1-D-ribityl group on N-8.


P1,P4-Bis(5'-xanthosyl) tetraphosphate

A purine ribonucleoside 5'-tetraphosphate compound having 5'-xanthosyl residues at the P(1)- and P(4)-positions.


5-O-Phosphono-D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminopyrimidine-2,4(1H,3H)-dione.


A myo-inositol tetrakisphosphate having the four phosphate groups placed at the 3-, 4-, 5- and 6-positions.


Huntington disease

Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia.


The (S)-enantiomer of 13-HPODE


Icomucret

An optically active form of 15-HETE having 15(S)-configuration..


A 3beta-sterol having the structure of desmosterol with an extra double bond at C-7--C-8.


A thiamine phosphate having a 1-hydroxyethyl substituent at the 2-position on the thiazolium ring and an O-diphosphate moiety.


3-Amino-2-methylpropanoic acid

A beta-amino-acid that is isobutyric acid in which one of the methyl hydrogens is substituted by an amino group.


Pentosidine

An imidazopyridine having norleucine and ornithine residues attached via their side-chains at the 4- and 2-positions respectively.


A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (S)-3-hydroxyhexanoyl-CoA.


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of all-cis-icosa-8,11,14-trienoic acid.


An androstanoid that is  testosterone with an oxo group at position 19.


L-selenomethionine

The L-enantiomer of selenomethionine.


NAA80_HUMAN N-alpha-acetyltransferase 80 (sprot)

An N-alpha-acetyltransferase 80 that is encoded in the genome of human.


beta-D-Fructose 6-phosphate

A D-fructofuranose 6-phosphate with a beta-configuration at the anomeric position.


1-phospho-alpha-D-glucuronic acid

The 1-O-phospho derivative of alpha-D-glucuronic acid.


A hydroxypregnenolone that is pregnenolone which has been substituted by a hydroxy group at position 21.


A 11beta-hydroxy steroid that is  progesterone substituted by a beta-hydroxy group at position 11.


An oxysterol that is the 22R-hydroxy derivative of cholesterol.


L-Allothreonine

The L-enantiomer of allothreonine.


A methyladenosine compound with one methyl group attached to N(6) of the adenine nucleobase.


Sulfopyruvate

A carboxyalkanesulfonic acid comprising pyruvic acid with a sulfo group attached at the C-3 position.


A member of the class of glycolaldehydes that is 3,4-dihydroxymandelaldehyde in which the hydroxy group at position 4 is replaced by a methoxy group.


A dihydroxybenzaldehyde carrying hydroxy groups at positions 2 and 5.


Leucodopachrome

Indoline substituted with hydroxy groups at C-5 and -6 and a carboxy group at C-2, and with S stereochemistry at C-2.


P_HUMAN P protein (sprot)

A P protein that is encoded in the genome of human.


A member of the class of  phenols that is  styrene carrying a hydroxy substituent at position 4.


An aldehyde that is acetaldehyde substituted by a 5-hydroxyindol-3-yl group.


A hydroxykynurenamine where the hydroxy group is located at the 5-position.


Quinoline substituted by hydroxy groups at the 4- and 6-positions. It is the product of 5-hydroxytryptophan metabolism, via monoamine oxidase catalysed conversion of 5-hydroxykynurenamine.


ABHD4_HUMAN (Lyso)-N-acylphosphatidylethanolamine lipase (sprot)

A (lyso)-N-acylphosphatidylethanolamine lipase that is encoded in the genome of human.


CNR1_HUMAN Cannabinoid receptor 1 (sprot)

A cannabinoid receptor 1 that is encoded in the genome of human.


Anandamide

An N-acylethanolamine 20:4 resulting from the formal condensation of carboxy group of arachidonic acid with the amino group of ethanolamine.


A member of the class of  tryptamines  that is melatonin with a hydroxy group substituent at position 6.


A dioxo monocarboxylic acid that is benzene in which the hydrogens at position 1, 2 and 3 are replaced by 3-carboxy-3-oxopropanoyl, amino and hydroxy groups, respectively. It is a by-product of tryptophan metabolism.


A non-proteinogenic alpha-amino acid that is 5-hydroxykynurenine bearing an N-formyl substituent.


2-(Formylamino)benzoic acid

An amidobenzoic acid consisting of anthranilic acid carrying an N-formyl group.


A member of the class of tryptamines that is the methyl ether derivative of serotonin.


5-Methoxyindole-3-acetic acid

A member of the class of indole-3-acetic acids in which the hydrogen at position 5 of indole-3-acetic acid has been replaced by a methoxy group.


An  aminopropionitrile carrying an amino group at the beta-position.


Adenylylselenate

The 5'-selenonooxyphosphate ester of adenosine.


Se-methylselenocysteine

An L-alpha-amino acid compound having methylselanylmethyl as the side-chain.


L-selenohomocysteine

A selenoamino acid that is the selenium analogue of L-homocysteine.


D-Threitol

The D-enantiomer of threitol.


A pyridone that is 2-pyridone substituted with a carboxamide group at C-5 and a methyl group at N-1.


A member of the class of 4-pyridones that is 4-pyridone substituted with a carboxamide group at C-3 and a methyl group at N-1.


Glutaurine

A dipeptide resulting from the formal condensation of the amino group of taurine with the gamma-carboxy group of L-glutamic acid. It was initially found in the parathyroid in 1980 and later in the brain of mammals.


Glu-lys

A dipeptide composed of L-glutamic acid and L-lysine joined by a peptide linkage.


Piceatannol

A stilbenol that is trans-stilbene in which one of the phenyl groups is substituted by hydroxy groups at positions 3 and 4, while the other phenyl group is substituted by hydroxy groups at positions 3 and 5.


Dexpanthenol

A monocarboxylic acid amide that is 3,3-dimethylbutanamide substituted by hydroxy groups at positions 2 and 4 and a 3-hydroxypropyl group at the carbomyl nitrogen.


A long-chain fatty acid consisting of leukotriene B4 having a 12-keto group in place of the 12-hydroxy group.


delta-12-Prostaglandin J2

A member of the class of prostaglandins J that is prosta-5,9,12-trien-1-oic acid carrying oxo and hydsroxy substituents at positions 11 and 15 respectively (the 5Z,12E,15S-stereoisomer).


A prostaglandin Falpha obtained by formal oxidation of the 15-hydroxy group of prostaglandin F2alpha.


6-ketoprostaglandin E1

A prostaglandin E that is prostaglandin E1 bearing a keto substituent at the 6-position.


The (S)-enantiomer of 12-HPETE.


The (S)-enantiomer of 15-HPETE.


FA12_HUMAN Coagulation factor XII (sprot)

A coagulation factor XII that is encoded in the genome of human.


KNG1_HUMAN Kininogen-1 (sprot)

A kininogen-1 that is encoded in the genome of human.


KLKB1_HUMAN Plasma kallikrein (sprot)

A plasma kallikrein that is encoded in the genome of human.


ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 (sprot)

An endoplasmic reticulum aminopeptidase 1 that is encoded in the genome of human.


NEUL_HUMAN Neurolysin, mitochondrial (sprot)

A neurolysin, mitochondrial that is encoded in the genome of human.


BKRB1_HUMAN B1 bradykinin receptor (sprot)

A B1 bradykinin receptor that is encoded in the genome of human.


Q71U72_HUMAN Bradykinin B1 receptor (Fragment) (trembl)


Q13833_HUMAN B2 bradykinin receptor basal promoter, allele BP-58-T (Fragment) (trembl)


Q13832_HUMAN B2 bradykinin receptor basal promoter, allele BP-58-C (Fragment) (trembl)


Q68DM8_HUMAN B2 bradykinin receptor (trembl)


Bradykinin

A linear nonapeptide messenger belonging to the kinin group of proteins, with amino acid sequence RPPGFSPFR. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation.


PLCX2_HUMAN PI-PLC X domain-containing protein 2 (sprot)

A PI-PLC X domain-containing protein 2 that is encoded in the genome of human.


PITC1_HUMAN Cytoplasmic phosphatidylinositol transfer protein 1 (sprot)

A cytoplasmic phosphatidylinositol transfer protein 1 that is encoded in the genome of human.


PLCX1_HUMAN PI-PLC X domain-containing protein 1 (sprot)

A PI-PLC X domain-containing protein 1 that is encoded in the genome of human.


PLCX3_HUMAN PI-PLC X domain-containing protein 3 (sprot)

A PI-PLC X domain-containing protein 3 that is encoded in the genome of human.


ASAP1_HUMAN Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (sprot)

An Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 that is encoded in the genome of human.


The pteridine that is lumazine substituted with a methyl group at C-6, a hydroxy group at C-7 and a 1-D-ribityl group at N-8.


Eicosanoyl-CoA

A very long-chain fatty acyl-CoA that is the S-icosanoyl derivative of coenzyme A.


An EET obtained by formal epoxidation of the 14,15-double bond of arachidonic acid.


Tyrosol

A phenol substituted at position 4 by a 2-hydroxyethyl group.


trans,trans-Farnesol

The (2-trans,6-trans)-stereoisomer of  farnesol.


Limonene, (-)-

An optically active form of limonene having (4S)-configuration.


A primary alcohol that is butane in which a hydrogen of one of the methyl groups is substituted by a hydroxy group. It it produced in small amounts in humans by the gut microbes.


The E (trans) stereoisomer of 4-hydroxynon-2-enal; it is the primary alpha,beta-unsaturated hydroxyalkenal produced by lipid peroxidation in cells.


N-Methylserotonin

A member of the class of tryptamines that is serotonin in which one of the hydrogens attached to the primary amino group is replaced by a methyl group.


2-Methoxyestrone 3-glucuronide

A steroid glucosiduronic acid that is 2-methoxyestrone having a single beta-D-glucuronic acid residue attached at position 3.


Estrone glucuronide

The 3-beta-D-glucuronide of estrone.


Geranylgeranyl diphosphate

The all-trans-isomer of geranylgeranyl diphosphate.


A myo-inositol tetrakisphosphate having the four phosphate groups at the 1-, 4-, 5- and 6-positions.


An androstanoid that is dehydroepiandrosterone carrying an additional hydroxy substituent at the 7alpha-position.


N-Acetyl-L-arginine

An N-acetyl-L-amino acid that is L-arginine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group.


S-(Hydroxymethyl)glutathione

An S-substituted glutathione that is glutathione in which the mercapto hydrogen has been replaced by a hydroxymethyl group.


An endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol.


An HODE (hydroxyoctadecadienoic acid) in which the double bonds are at positions 9 and 11 (E and Z geometry, respectively) and the hydroxy group is at position 13 (with S-configuration).


13-keto-9Z,11E-octadecadienoic acid

An oxooctadecadienoic acid that consists of 9Z,11E-octadecadienoic acid bearing an additional 13-keto substituent. In addtion it has been found as a natural product found in Carthamus oxyacantha.


A 9-HODE in which the 9-hydroxy group has S-stereochemistry.


An 11,12-EET in which the epoxy moiety has 11S,12R-configuration.


A HETE having an (8S)-hydroxy group and (5Z)-, (9E)-, (11Z)- and (14Z)-double bonds.


A 16-HETE in which the chiral centre at position 16 has R-configuration.


A HPETE that is (5Z,8Z,10E,12R,14Z)-icosa-5,8,10,14-tetraenoic acid with the hydroperoxy group located at position 12 (the R-enantiomer).


A trihydroxyicosatrienoic acid that is (5Z,8Z,12E)-icosatrienoic acid in which the three hydroxy groups are located at positions 11, 14 and 15.


A HPETE in which the hydroperoxy group is located at position 8S and the four double bonds at position 5, 9, 11 and 14 (the 5Z,9E,11Z,14Z-geoisomer).


Coronaric acid

An EpOME obtained by formal epoxidation of the 9,10-double bond of octadeca-9,12-dienoic acid (the 12Z-geoisomer).


A monounsaturated epoxy fatty acid composed of cis-9-octadecenoic acid having a 12,13-epoxy group.


A dialkyl ketone that is heptane in which the two methylene protons at position 4 have been replaced by an oxo group.


Synephrine

A  phenethylamine alkaloid that is 4-(2-aminoethyl)phenol substituted by a hydroxy group at position 1 and a methyl group at the amino nitrogen.


Stachydrine

An amino acid betaine that is L-proline zwitterion in which both of the hydrogens attached to the nitrogen are replaced by methyl groups.


A beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine in which the acyl group specified is (15Z)-tetracosenoyl.


A beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine in which the acyl group specified is (17Z)-hexacosenoyl.


A beta-D-galactosyl-(1->4)-beta-D-glucosylceramide where the ceramide N-acyl group is specified as hexacosanoyl.


hemolytic uremic syndrome, atypical, susceptibility to, 1


Laurylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as dodecanoyl (lauroyl).


Fabry disease

Fabry disease (FD) is a progressive, inherited, multisystemic lysosomal storage disease characterized by specific neurological, cutaneous, renal, cardiovascular, cochleo-vestibular and cerebrovascular manifestations.


N-(oleoyl)-ceramide

A N-acylsphingosine in which the ceramide N-acyl group is specified as oleoyl.


N-Palmitoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as hexadecanoyl (palmitoyl).


N-Stearoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as octadecanoyl (stearoyl).


N-icosanoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as eicosanoyl.


N-docosanoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as docosanoyl.


An N-tetracosenoylsphingosine in which the double bond in the ceramide acyl group is located at position 15 (the Z-geoisomer.


N-hexacosanoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as hexacosanoyl.


N-tetracosanoylsphingosine

A N-acylsphingosine in which the ceramide N-acyl group is specified as tetracosanoyl.


N-(pentacosanoyl)-ceramide

A N-acylsphingosine in which the ceramide N-acyl group is specified as pentacosanoyl.


A D-glucosyl-N-acylsphingosine in which the ceramide N-acyl group is dodecanoyl.


An N-acyl-beta-D-galactosylsphingosine where the ceramide N-acyl group is specified as oleoyl.


A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as hexadecanoyl.


A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as octadecanoyl.


beta-D-glucosyl-N-eicosanoylsphingosine

A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as eicosanoyl.


Glucosylceramide (d18:1/22:0)

A beta-D-glucosylceramide where the ceramide N-acyl group is specified as docosanoyl.


C24:1 GlcCer

A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as (15Z)-tetracosenoyl.


A beta-D-glucosyl-N-acylsphingosine in which the acyl group is specified as (17Z)-hexacosenoyl.


A beta-D-glucosylceramide where the ceramide N-acyl group is specified as hexacosanoyl.


m-Tyramine

A primary amino compound that is 2-phenylethanamine substituted by a hydroxy group at position 3.


Benzocaine

A benzoate ester having 4-aminobenzoic acid as the acid component and ethanol as the alcohol component. A surface anaesthetic, it is used to suppress the gag reflex, and as a lubricant and topical anaesthetic on the larynx, mouth, nasal cavity, respiratory tract, oesophagus, rectum, urinary tract, and vagina.


Codeine

A  morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties.


Loperamide

A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.


Loratadine

A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.


PAI1_HUMAN Plasminogen activator inhibitor 1 (sprot)

A plasminogen activator inhibitor 1 that is encoded in the genome of human.


CD40L_HUMAN CD40 ligand (sprot)

A tumor necrosis factor ligand superfamily member 5 that is encoded in the genome of human.


CODA1_HUMAN Collagen alpha-1(XIII) chain (sprot)

A collagen alpha-1(XIII) chain that is encoded in the genome of human.


Atorvastatin

A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.


IFNG_HUMAN Interferon gamma (sprot)

An interferon gamma that is encoded in the genome of human.


ITB2_HUMAN Integrin beta-2 (sprot)

An integrin beta-2 that is encoded in the genome of human.


IL6_HUMAN Interleukin-6 (sprot)

An interleukin-6 that is encoded in the genome of human.


ICAM1_HUMAN Intercellular adhesion molecule 1 (sprot)

An intercellular adhesion molecule 1 that is encoded in the genome of human.


BMP2_HUMAN Bone morphogenetic protein 2 (sprot)

A bone morphogenetic protein 2 that is encoded in the genome of human.


TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 (sprot)

A tumor necrosis factor receptor superfamily member 5 that is encoded in the genome of human.


TNFC_HUMAN Lymphotoxin-beta (sprot)

A lymphotoxin-beta that is encoded in the genome of human.


Simvastatin

A member of the class of hexahydronaphthalenes that is lovastatin in which the 2-methylbutyrate ester moiety has been replaced by a 2,2-dimethylbutyrate ester group. It is used as a cholesterol-lowering and anti-cardiovascular disease drug.


Lansoprazole Metabolism Pathway,Drug Metabolism

biolink:Pathway biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:OntologyClass biolink:Occurrent biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent


Esomeprazole Metabolism Pathway,Drug Metabolism


Esomeprazole

A 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has S configuration at the sulfur atom. An inhibitor of gastric acid secretion, it is used (generally as its sodium or magnesium salt) for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome.


Sertraline

A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.


Clopidogrel

A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group, the methylene hydrogen of which is replaced by a  methoxycarbonyl group (the S enantiomer). A P2Y12 receptor antagonist, it is used to inhibit blood clots and prevent heart attacks.


ACM3_HUMAN Muscarinic acetylcholine receptor M3 (sprot)

A muscarinic acetylcholine receptor M3 that is encoded in the genome of human.


ACM2_HUMAN Muscarinic acetylcholine receptor M2 (sprot)

A muscarinic acetylcholine receptor M2 that is encoded in the genome of human.


ACM4_HUMAN Muscarinic acetylcholine receptor M4 (sprot)

A muscarinic acetylcholine receptor M4 that is encoded in the genome of human.


ACM5_HUMAN Muscarinic acetylcholine receptor M5 (sprot)

A muscarinic acetylcholine receptor M5 that is encoded in the genome of human.


Olanzapine

A benzodiazepine that is 10H-thieno[2,3-b][1,5]benzodiazepine substituted by a methyl group at position 2 and a 4-methylpiperazin-1-yl group at position 4.


Celecoxib

A member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and p-tolyl groups, respectively. A cyclooxygenase-2 inhibitor, it is used in the treatment of arthritis.


Gabapentin

A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.


Venlafaxine

A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group.


Pantoprazole

A member of the class of  benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.


Amlodipine

A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.


Risperidone

A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.


ENK11_HUMAN Putative endogenous retrovirus group K member 11-1 Env polyprotein (sprot)


Pravastatin

A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.


Zolpidem

An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.


Escitalopram

A 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile that has S-configuration at the chiral centre. It is the active enantiomer of citalopram.


Fexofenadine

A piperidine-based anti-histamine compound.


Cetirizine

A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.


Valdecoxib

A member of the class of isoxazoles that is isoxazole which is substituted at positions 3, 4 and 5 by phenyl, p-sulfamoylphenyl and methyl groups, respectively. A selective cyclooxygenase 2-inhibitor, it used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of arthritis from 2001 until 2005, when it was withdrawn following concerns of an associated increased risk of heart attack and stroke.


Topiramate

A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine.


5HT6R_HUMAN 5-hydroxytryptamine receptor 6 (sprot)

A 5-hydroxytryptamine receptor 6 that is encoded in the genome of human.


Fluticasone Propionate

A trifluorinated corticosteroid that consists of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity.


AKT1_HUMAN RAC-alpha serine/threonine-protein kinase (sprot)

A RAC-alpha serine/threonine-protein kinase that is encoded in the genome of human.


Sumatriptan

A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.


Citalopram

A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer,  escitalopram. It is used as an antidepressant, although only escitalopram is active.


Sildenafil

A pyrazolo[4,3-d]pyrimidin-7-one having a methyl substituent at the 1-position, a propyl substituent at the 3-position and a 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl group at the 5-position.


Donepezil

A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.


Aripiprazole

An N-arylpiperazine that is piperazine substituted by a 4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butyl group at position 1 and by a 2,3-dichlorophenyl group at position 4. It is an antipsychotic drug used for the treatment of Schizophrenia, and other mood disorders.


9,11-Octadecadienoic acid

An octadeca-9,11-dienoic acid having 9-trans,11-trans-stereochemistry.


Eicosadienoic acid

An icosadienoic acid with double bonds at positions 11 and 14 (both Z).


oleoyl-L-carnitine

An O-acyl-L-carnitine in which the acyl group is specified as oleoyl.


Tetradecanoylcarnitine

An O-acyl-L-carnitine in which the acyl group is specified as myristoyl (tetradecanoyl).


15-Deoxy-delta-12,14-prostaglandin J2

A prostaglandin J derivative comprising prostaglandin J2 lacking the 15-hydroxy group and having C=C double bonds at the 12- and 14-positions.


A leukotriene that is the 12S-isomer of leukotriene B4.


N-arachidonoylglycine

Biologically active derivative of anandamide


An isoquinolinol that is 1,2,3,4-tetrahydroisoquinoline substituted by a methyl group at position 1 and by hydroxy groups at positions 6 and 7.


Tripalmitin

A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by palmitic (hexadecanoic) acid.


The S-enantiomer of 1,2-dioleoyl-3-palmitoylglycerol.


CETP_HUMAN Cholesteryl ester transfer protein (sprot)

A cholesteryl ester transfer protein that is encoded in the genome of human.


APOC3_HUMAN Apolipoprotein C-III (sprot)

An apolipoprotein C-III that is encoded in the genome of human.


APOA4_HUMAN Apolipoprotein A-IV (sprot)

An apolipoprotein A-IV that is encoded in the genome of human.


CD36_HUMAN Platelet glycoprotein 4 (sprot)

A platelet glycoprotein 4 that is encoded in the genome of human.


Tristearin

A triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with stearic acid.


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specifed as stearoyl.


Tripalmitolein

A triglyceride formed by acylation of the three hydroxy groups of glycerol with palmitoleic acid.


Glyceryl Trioleate

A triglyceride formed by esterification of the three hydroxy groups of glycerol with oleic acid. Triolein is one of the two components of Lorenzo's oil.


Trilinolein

A triglyceride formed by acylation of the three hydroxy groups of glycerol with linoleic acid.


Dihydrodaidzein

A hydroxyisoflavanone that is isoflavanone carrying two hydroxy substituents located at positions 4' and 7.


Glycitein

A  methoxyisoflavone that is isoflavone substituted by a methoxy group at position 6 and hydroxy groups at positions 7 and 4'. It has been isolated from the mycelia of the fungus Cordyceps sinensis.


Hesperetin

A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position.


Quercetin

A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions. It is one of the most abundant flavonoids in edible vegetables, fruit and wine.


Luteolin

A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers.


Kaempferol

A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7 and 4'. Acting as an antioxidant by reducing oxidative stress, it is currently under consideration as a possible cancer treatment.


Gallic Acid

A trihydroxybenzoic acid in which the hydroxy groups are at positions 3, 4, and 5.


Eugenol

A phenylpropanoid formally derived from guaiacol with an allyl chain substituted para to the hydroxy group. It is a major component of clove essential oil, and exhibits antibacterial, analgesic and antioxidant properties. It has been widely used in dentistry to treat toothache and pulpitis.


Eriodictyol

A tetrahydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 7, 3' and 4' respectively.


Nerol

The (2Z)-stereoisomer of 3,7-dimethylocta-2,6-dien-1-ol. It has been isolated from the essential oils from plants like lemon grass.


GALACTINOL

An alpha-D-galactoside having a 1D-myo-inositol substituent at the anomeric position.


Dimethyl Disulfide

An organic disulfide that is methane in which one of the hydrogens has been replaced by a methyldisulfanyl group.


Dihydrogenistein

A hydroxyisoflavanone comprising isoflavanone carrying three hydroxy substituents at positions 5, 7 and 4'.


Hexanal

A saturated fatty aldehyde that is hexane in which one of the terminal methyl group has been mono-oxygenated to form the corresponding aldehyde.


20-Hydroxyeicosatetraenoic acid

A HETE that consists of arachidonic acid bearing a hydroxy substituent at position 20.


Isobutanol

An alkyl alcohol that is propan-1-ol substituted by a methyl group at position 2.


Isoamyl alcohol

An primary alcohol that is butan-1-ol in which a hydrogen at position 3 has been replaced by a methyl group.


Aceglutamide

An N(2)-acetylglutamine that has L-configuration.


20-Carboxy-leukotriene B4

A member of the class of leukotrienes that is leukotriene B4 in which the terminal methyl group has undergone formal oxidation to the corresponding carboxylic acid.


A HETE having a (12S)-hydroxy group and (5Z)-, (8Z)-, (10E)- and (14Z)-double bonds.


Malonaldehyde

A dialdehyde that is propane substituted by two oxo groups at the terminal carbon atoms respectively. A biomarker of oxidative damage to lipids caused by smoking, it exists in vivo mainly in the enol form.


Benzaldehyde

An arenecarbaldehyde that consists of benzene bearing a single formyl substituent; the simplest aromatic aldehyde and parent of the class of benzaldehydes.


3-Hydroxyhippuric acid

An N-acylglycine that is hippuric acid (N-benzoylglycine) substituted at position 3 on the phenyl ring by a hydroxy group.


4,8 Dimethylnonanoyl carnitine

An O-acylcarnitine compound having 4,8-dimethylnonanoyl as the acyl substituent.


5-alpha-Dihydrotestosterone glucuronide

A steroid glucosiduronic acid that is 5alpha-dihydrotestosterone having a single beta-D-glucuronic acid residue attached at position 17.


A retinol in which the double bond at position 9 has cis configuration, whilst the remaining acyclic double bonds have trans configuration.


AKA10_HUMAN A-kinase anchor protein 10, mitochondrial (sprot)

An A-kinase anchor protein 10, mitochondrial that is encoded in the genome of human.


A retinal in which the double bond at position 9 has cis configuration, whilst the remaining acyclic double bonds have trans configuration.


Isotretinoin

A retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases.


17beta-Estradiol 3-(beta-D-glucuronide)

A steroid glucosiduronic acid that consists of 17beta-estradiol having a beta-glucuronyl residue attached at position 3 via a glycosidic linkage.


Ercalcitriol

A hydroxycalciol that is vitamin D2 bearing additional hydroxy substituents at positions 1alpha and 25.


A myo-inositol pentakisphosphate that consists of 1D-myo-inositol having the five phospho groups located at positions 1, 2, 3, 4 and 6 as well as a diphospho group at position 5.


Bisdiphosphoinositol tetrakisphosphate

A 1D-myo-inositol bis(diphosphate) tetrakisphosphate having the two diphospho groups located at positions 5 and 6.


Phenylacetaldehyde

An aldehyde that consists of acetaldehyde bearing a methyl substituent; the parent member of the phenylacetaldehyde class of compounds.


A hydroxyaldehyde consisting of phenylacetaldehyde having three hydroxy substituents located at the alpha-, 3- and 4-positions. It is a metabolite of noradrenaline.


18-Hydroxy-arachidonic acid

An 18-HETE in which the 18-hydroxy group has R-configuration.


OSBP1_HUMAN Oxysterol-binding protein 1 (sprot)

An oxysterol-binding protein 1 that is encoded in the genome of human.


gamma-Glutamylalanine

A gamma-glutamylalanine obtained by formal condensation of the gamma-carboxy group of L-glutamic acid with the amino group of L-alanine.


4-Hydroxyretinoic acid

A retinoid that consists of all-trans-retinoic acid bearing a hydroxy substituent at position 4 on the cyclohexenyl ring.


Linoelaidic acid

An octadecadienoic acid containing two E (trans) double bonds at positions 9 and 12.


An oxysterol that is cholesterol which is substituted by hydroxy groups at the 7alpha and 26 positions.


L-2,4-diaminobutyric acid

A 2,4-diaminobutyric acid that has S-configuration.


All-trans-4-oxoretinoic acid

A retinoid that consists of all-trans-retinoic acid bearing an oxo substituent at position 4 on the cyclohexenyl ring.


trans-Hexadec-2-enoyl carnitine

An O-hexadecenoylcarnitine having (2E)-hexadecenoyl as the acyl substituent.


alpha-D-mannose 1-phosphate

A D-mannose 1-phosphate with an alpha-configuration at the anomeric position.


A derivative of L-gulonic acid having a keto group at the 3-position.


beta-Tocopherol

A tocopherol in which the chroman-6-ol core is substituted by methyl groups at positions 5 and 8. While it is found in low concentrations in many vegetable oils, only cottonseed oil contains significant amounts.


L-Selenocystathionine

An optically active form of selenocystathionine in which both amino acid residues have L-configuration.


Phenylacetylglutamine

An a N(2)-phenylacetylglutamine having L-configuration.


GLCE_HUMAN D-glucuronyl C5-epimerase (sprot)

A D-glucuronyl C5-epimerase that is encoded in the genome of human.


gamma-Linolenoyl-CoA

An octadecatrienoyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of gamma-linolenic acid.


(2S)-2,3-dihydroxypropanoic acid

An optically active form of glyceric acid having L-configuration.


(R)-Lactaldehyde

The (R)-stereoisomer of lactaldehyde.


hexacosanoyl-CoA

A very long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of hexacosanoic (cerotic) acid..


Leukotriene F4

A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents.


O-linoleyl-L-carnitine

An O-octadecadienoyl-L-carnitine where the acyl group specified is linoleyl.


Isovaleraldehyde

A methylbutanal that is butanal substituted by a methyl group at position 3. It occurs as a volatile constituent in olives.


A cationic phosphosphingolipid consisting of sphingosine having a phosphocholine moiety attached to its primary hydroxyl group.


D-Aspartic acid

The D-enantiomer of aspartic acid.


Heptadecanoyl-coa

A long-chain  fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of heptadecanoic acid,


phenylacetyl-CoA

An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of phenylacetic acid.


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (4Z,7Z,10Z,13Z,16Z)-docosapentaenoic acid


(+)-alpha-Pinene

The (+)-enantiomer of alpha-pinene.


Docosapentaenoic acid

The all-cis-isomer of a C22 polyunsaturated fatty acid having five double bonds in the 7-, 10-, 13-, 16- and 19-positions.


beta-mannosidosis

Beta-mannosidosis is a very rare lysosomal storage disease characterized by developmental delay of varying severity and hearing loss, but that can manifest a wide phenotypic heterogeneity.


An amino disaccharide comprising a beta-D-mannose residue linked (1->4) to an N-acetyl-beta-D-glucosamine residue at the reducing end.


Stearidonic acid

An octadecatetraenoic acid having four double bonds located at positions 6, 9, 12 and 15 (the all-cis-isomer). It has been isolated from Lithospermum officinale and fish oils.


ARK73_HUMAN Aflatoxin B1 aldehyde reductase member 3 (sprot)

An aflatoxin B1 aldehyde reductase member 3 that is encoded in the genome of human.


Aflatoxin B1

An aflatoxin having a tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11.


2'-Deoxyinosine 5'-monophosphate

A deoxyinosine phosphate that is 5'-inosinic acid in which the hydroxy group at position 2' by a hydrogen atom.


L-4-Hydroxyglutamate semialdehyde

A glutamic semialdehyde that is  L-glutamic 5-semialdehyde substituted by a hydroxy group at position 4.


The beta anomer of beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc.


CHST5_HUMAN Carbohydrate sulfotransferase 5 (sprot)

A carbohydrate sulfotransferase 5 that is encoded in the genome of human.


B3GN8_HUMAN UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 (sprot)

A UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 that is encoded in the genome of human.


SIA7F_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (sprot)

An alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 that is encoded in the genome of human.


Any benzoquinone derived from 2,3-dimethoxy-5-methylbenzoquinone; one of a group of naturally occurring homologues. The redox-active quinoid moiety usually carries a polyprenoid side chain at position 6, the number of isoprenoid units in which is species-specific. Ubiquinones are involved in the control of mitochondrial electron transport, and are also potent anti-oxidants.


Cholesteryl myristate

A cholesterol ester obtained by the formal condensation of the hydroxy group of cholesterol with the carboxy group of myristic acid.


Cholest-5-en-3beta-yl nonadecanoate

A cholesterol ester derived obtained by formal condensation of the carboxy group of nonadecanoic acid with the 3-hydroxy group of cholesterol.


A 1,3-thiazolium cation that is 1,3-thiazol-3-ium substituted by a methyl group at position 4, a (4-amino-2-methylpyrimidin-5-yl)methyl group at position 3, a 3-carboxy-1-hydroxypropyl at position 2 and a 2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl group at position 5.


A beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphingosine in which the acyl group specified is hexadecanoyl.


DEGS2_HUMAN Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (sprot)

A sphingolipid Delta(4)-desaturase/C4-monooxygenase DES2 that is encoded in the genome of human.


A 4,5-dihydrocortisone that has beta- configuration at position 5.


A steroid glucosiduronic acid that is 2-methoxy-17beta-estradiol having a single beta-D-glucuronic acid residue attached at position 3.


A steroid glucosiduronic acid that is estriol in which the phenolic hydrogen has been replaced by a beta-D-glucuronyl residue.


A 17beta-hydroxyandrostan-3-one that has beta- configuration at position 5. It is a metabolite of testosterone.


Adrenosterone

A 3-oxo Delta(4)-steroid that is androst-4-ene carrying three oxo-substituents at positions 3, 11 and 17.


Lactose 6-phosphate

A lactose phosphate in which a single monophosphate substituent is placed at position 6 on the galactose ring of lactose.


A 3-D-galactosyl glycerol in which the carbon bearing the anomeric hydrogen has beta configuration.


Diquafosol

A pyrimidine ribonucleoside 5'-tetraphosphate compound having 5'-uridinyl residues at the P(1)- and P(4)-positions.


beta-D-Fructose 2-phosphate

The beta-anomer of D-fructofuranose 2-phosphate.


A 2-oxo monocarboxylic acid that is 2-oxobutanoic acid which is substituted by a phosphonooxy group at position 4 and a hydroxy group at the 3-pro-R position.


Propiolic acid

A terminal acetylenic compound that is a 3-carbon, straight-chain, monounsaturated fatty acid having one acetylenic bond.


propanoyl-AMP

A purine ribonucleoside 5'-monophosphate consisting of adenosine 5'-monophosphate where one of the hydroxy groups of the phosphate has been condensed with propionic acid.


D-ribosylnicotinic acid

A pyridine nucleoside consisting of nicotinic acid with a beta-D-ribofuranosyl moiety at the 1-position.


A monomethoxybenzene that is 6-methoxyphenol substituted by a (all-trans)-hexaprenyl group at position 2.


A ribose 5-triphosphate compound having a 2,5-diamino-6-oxo-1,6-dihydropyrimidin-4-ylamino substituent at the 1-position.


A tetrahydrofolyl glutamate consisting of a tetrahydrofolyl group linked via an amide bond to a poly(gamma-glutamyl chain)


2-Hydroxy-2-methyl-3-oxobutanoic acid

A derivative of butyric acid having methyl, hydroxy and oxo substituents at the 2-, 2- and 3-positions respectively.


A 3beta-sterol formed from lanosterol by reduction across the C-24-C-25 double bond.


Zymostenol

A cholestanoid that is 5alpha-cholestane substituted by a beta-hydroxy group at position 3.


A 3beta-sterol having double bonds in the 5- and 7-positions and a methylene group at position 24.


A 3beta-sterol having the structure of cholesterol with a methylene group at C-24.


A stigmastane sterol that is 5alpha-stigmastane carrying a hydroxy group at position 3beta and double bonds at positions 7 and 24.


A butynal which has a monosubstituted triple bond.


The diphosphate of thiamine(1+), substituted at C-2 of the thiazole ring by a hydroxylated sec-butyl group.


D-tagatofuranose 1,6-bisphosphate

The furanose form of D-tagatose 1,6-bisphosphate.


D-tagatose 6-phosphate

The furanose form of D-tagatose 6-phosphate.


A 3-oxo monocarboxylic acid that is butanoic acid in which the hydrogens at position 2 are replaced by an acetyl and a hydroxy group (the S enantiomer).


Adenosylcobinamide

A cobalt-corrinoid hexaamide comprising cobinamide having an adenosyl group attached to cobalt.


A 2-hydroxy monocarboxylic acid that is acrylic acid in which the hydrogen at position 2 is substituted by a hydroxy group and a hydrogen at position 3 is substituted by a 4-hydroxyphenyl group.


An isoquinoline alkaloid having a tetrahydroisoquinoline core with 3,4-dihydroxybenzyl, methoxy and hydroxy groups at the 1-, 6- and 7-positions respectively; major species at pH 7.3.


A 3beta-sterol that is methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol carrying an additional 4alpha-methyl substituent.


A pyridinemonocarboxylic acid that is pyridine-4-carboxylic acid substituted by a methyl group, hydroxy group and formyl group at positions 2,3 and 5, respectively.


Hydroxyacetone

A propanone that is acetone in which one of the methyl hydrogens is replaced by a hydroxy group.


DGKE_HUMAN Diacylglycerol kinase epsilon (sprot)

A diacylglycerol kinase epsilon that is encoded in the genome of human.


RASF1_HUMAN Ras association domain-containing protein 1 (sprot)

A Ras association domain-containing protein 1 that is encoded in the genome of human.


KSR2_HUMAN Kinase suppressor of Ras 2 (sprot)

A kinase suppressor of Ras 2 that is encoded in the genome of human.


TENS2_HUMAN Tensin-2 (sprot)

A tensin-2 that is encoded in the genome of human.


Q59FI5_HUMAN protein kinase C (Fragment) (trembl)


KSR1_HUMAN Kinase suppressor of Ras 1 (sprot)

A kinase suppressor of Ras 1 that is encoded in the genome of human.


Q59EZ0_HUMAN Protein kinase C, gamma variant (Fragment) (trembl)


Q8IWQ7_HUMAN non-specific serine/threonine protein kinase (trembl)


Q7Z727_HUMAN PRKCA protein (Fragment) (trembl)


STAC3_HUMAN SH3 and cysteine-rich domain-containing protein 3 (sprot)

An SH3 and cysteine-rich domain-containing protein 3 that is encoded in the genome of human.


GMIP_HUMAN GEM-interacting protein (sprot)

A GEM-interacting protein that is encoded in the genome of human.


DEFI8_HUMAN Differentially expressed in FDCP 8 homolog (sprot)

A differentially expressed in FDCP 8 that is encoded in the genome of human.


RHG29_HUMAN Rho GTPase-activating protein 29 (sprot)

A Rho GTPase-activating protein 29 that is encoded in the genome of human.


PKHM3_HUMAN Pleckstrin homology domain-containing family M member 3 (sprot)

A pleckstrin homology domain-containing family M member 3 that is encoded in the genome of human.


HMHA1_HUMAN Rho GTPase-activating protein 45 (sprot)

A Rho GTPase-activating protein 45 that is encoded in the genome of human.


Q4LE73_HUMAN UNC13B variant protein (Fragment) (trembl)


PKHM1_HUMAN Pleckstrin homology domain-containing family M member 1 (sprot)

A pleckstrin homology domain-containing family M member 1 that is encoded in the genome of human.


STAC2_HUMAN SH3 and cysteine-rich domain-containing protein 2 (sprot)

An SH3 and cysteine-rich domain-containing protein 2 that is encoded in the genome of human.


CHIO_HUMAN Beta-chimaerin (sprot)

A beta-chimaerin that is encoded in the genome of human.


SNTG1_HUMAN Gamma-1-syntrophin (sprot)

A gamma-1-syntrophin that is encoded in the genome of human.


CHIN_HUMAN N-chimaerin (sprot)

An N-chimaerin that is encoded in the genome of human.


MYO9A_HUMAN Unconventional myosin-IXa (sprot)

A myosin-IXa that is encoded in the genome of human.


RASF5_HUMAN Ras association domain-containing protein 5 (sprot)

A Ras association domain-containing protein 5 that is encoded in the genome of human.


PDZD8_HUMAN PDZ domain-containing protein 8 (sprot)

A PDZ domain-containing protein 8 that is encoded in the genome of human.


VAV_HUMAN Proto-oncogene vav (sprot)

A proto-oncogene vav that is encoded in the genome of human.


STAC_HUMAN SH3 and cysteine-rich domain-containing protein (sprot)

An SH3 and cysteine-rich domain-containing protein that is encoded in the genome of human.


RGAP1_HUMAN Rac GTPase-activating protein 1 (sprot)

A Rac GTPase-activating protein 1 that is encoded in the genome of human.


A 1,2-diacyl-sn-glycerol in which both acyl groups are tetradecanoyl (myristoyl).


A 1,2-diacyl-sn-glycerol that has myristoyl and palmitoyl as 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol with myristoyl and palmitoleoyl as 1- and 2-acyl groups respectively.


A  1,2-diacyl-sn-glycerol that has myristoyl and oleoyl as 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol that has myristoyl and linoleoyl as 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are both myristoleoyl groups.


A diacylglycerol 34:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-tetradecenoyl and (5Z,8Z,11Z,14Z)-icosatetraenoyl respectively.


A 1,2-diacyl-sn-glycerol that has pentadecanoyl as 1- and 2-acyl groups.


A 1,2-diacyl-sn-glycerol that has palmitoyl and tetradecanoyl as 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as palmitoyl (hexadecanoyl).


A 1,2-diacyl-sn-glycerol that has palmitoyl and palmitoleoyl as 1- and 2-acyl groups respectively.


A diacylglycerol 34:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and octadecanoyl respectively.


A 1,2-diacyl-sn-glycerol with palmitoyl as the 1-acyl group and oleoyl as the 2-acyl group.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (11Z,14Z)-eicosadienoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (8Z,11Z,14Z-eicosatrienoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


A diacylglycerol 38:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and docosanoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl  respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as palmitoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl and stearoyl respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as palmitoleoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycerol where both acyl groups are specified as octadecanoyl.


A 1,2-diacyl-sn-glycerol that has stearoyl and oleoyl as the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and 8Z,11Z,14Z-icosa-8,11,14-trienoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specifed as stearoyl and arachidonoyl respectively.


A diacylglycerol 40:0 in which the acyl groups at positions 1 and 2 are octadecanoyl and docosanoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and 7Z,10Z,13Z,16Z-docosatetraenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A diacylglycerol 34:1 in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and hexadecanoyl respectively.


A 1,2-diacyl-sn-glycerol where oleoyl and myristoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as oleoyl and palmitoyl respectively.


A 1,2-diacyl-sn-glycerol where oleoyl and stearoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl.


A 1,2-diacyl-sn-glycerol where oleoyl and linoleoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the 1- and 2-acyl groups are specified as oleoyl and alpha-linolenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and gondoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 8Z,11Z,14Z-eicosatrienoyl respectively.


A 1,2-diacyl-sn-glycerol where oleoyl and arachidonoyl are the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 7Z,10Z,13Z,16Z-docosatetraenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl and 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as (9Z,12Z)-octadecadienoyl and octadecanoyl respectively.


A 1,2-diacyl-sn-glycerol where linoleoyl and oleoyl form the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which both acyl groups are specified as linoleoyl.


A diacylglycerol 38:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and  icosanoyl respectively.


A 1,2-diacyl-sn-glycerol where alpha-linolenoyl and oleoyl form the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and icosanoyl (arachidoyl) respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (11Z)-icosenoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (11Z,14Z)-icosadienoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (5Z,8Z,11Z)-icosatrienoyl respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups positions 1 and 2 are specified as alpha-linolenoyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


A diacylglycerol 40:10 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z,15Z)-octadecatetraenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A  1,2-diacyl-sn-glycerol where icosanoyl and oleoyl are the 1- and 2-acyl groups respectively.


A diacylglycerol 40:5 in which the acyl groups specified are  icosanoyl and (5Z,8Z,11ZZ,14Z,17Z)-eicosapentaenoyl respectively,


A  1,2-diacyl-sn-glycerol where arachidonoyl and oleoyl form the 1- and 2-acyl groups respectively.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as 7Z,10Z,13Z,16Z-docosatetraenoyl.


A 1,2-diacyl-sn-glycerol in which both the acyl groups are specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


LPAR1_HUMAN Lysophosphatidic acid receptor 1 (sprot)

A lysophosphatidic acid receptor 1 that is encoded in the genome of human.


LPAR3_HUMAN Lysophosphatidic acid receptor 3 (sprot)

A lysophosphatidic acid receptor 3 that is encoded in the genome of human.


LPAR5_HUMAN Lysophosphatidic acid receptor 5 (sprot)

A lysophosphatidic acid receptor 5 that is encoded in the genome of human.


B1AP63_HUMAN Lysophosphatidic acid receptor 1 (Fragment) (trembl)


O43898_HUMAN High-affinity lysophosphatidic acid receptor homolog (trembl)


Q6GPG7_HUMAN Lysophosphatidic acid receptor 1 (trembl)


1-Palmitoylglycerol 3-phosphate

A monoacylglycerol phosphate having palmitoyl as the acyl group on O-1 and with the phosphate group on O-3.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl groups are palmitoyl and oleoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively.


A 1-acyl-2-linoleoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as stearoyl (octadecanoyl).


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and (11Z)-octadecenoyl respectively.


A 1-acyl-2-oleoyl-sn-glycerol-3-phosphate(2-) in which the 1-acyl group is also oleoyl.


A 1,2-diacyl-sn-glycero-3-phosphocholine where the two phosphatidyl acyl groups are specified as tetradecanoyl (myristoyl).


A phosphatidylcholine 29:0 in which the fatty acyl groups at positions 1 and 2 are specified as tetradecanoyl and pentadecanoyl respectively


A phosphatidylcholine 30:0 in which the phosphatidyl acyl groups at positions 1 and 2 are myristoyl (tetradecanoyl) and palmitoyl (hexadecanoyl) respectively.


A phosphatidylcholine 30:1 in which the acyl groups at positions 1 and 2 are myristoyl and palmitoleoyl respectively.


A phosphatidylcholine 32:0 in which the acyl group specified at positions 1 and 2 are myristoyl and stearoyl respectively.


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (11Z)-octadec-11-enoyl respectively.


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 32:2 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (9Z,12Z)-octadecadienoyl respectively.


A phosphatidylcholine 32:3 in which the acyl groups at positions 1 and 2 are tetradecanoyl and (9Z,12Z,15Z)-octadecatrienoyl respectively.


A phosphatidylcholine 34:4 in which teh acyl groups specified at positions 1 and 2 are tetradecanoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


A phosphatidylcholine 36:0 in which the acyl groups at positions 1 and 2 are tetradecanoyl and docosanoyl respectively.


A phosphatidylcholine 36:6 in which the acyl groups at positions 1 and 2 tetradecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and tetracosanoyl respectively.


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are tetradecanoyl and (15Z)-tetracosenoyl respectively.


A  phosphatidylcholine 30:0 in which the acyl group specified at positions 1 and 2 is pentadecanoyl.


A phosphatidylcholine 31:0 in which the fatty acyl groups at positions 1 and 2 are specified as pentadecanoyl and hexadecanoyl respectively


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1- and 2-acyl groups are specified as pentadecanoyl and octadecanoyl respectively.


A phosphatidylcholine 33:1 in which the 1- and 2-acyl groups are specified as pentadecanoyl and oleoyl respectively.


A phosphatidylcholine 33:2 in which the 1- and 2-acyl groups are specified as pentadecanoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at positions 1 and 2 are pentadecanoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


A phosphatidylcholine 30:0 in which the phosphatidyl acyl groups at positions 1 and 2 are palmitoyl (hexadecanoyl) and myristoyl (tetradecanoyl) respectively.


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are hexadecanoyl and (9Z)-hexadec-9-enoyl respectively.


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 11Z-octadecenoyl (cis-vaccenoyl) respectively.


A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively.


Lecithin

A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively.


A phosphatidylcholine 34:3 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (6Z,9Z,12Z)-octadecatrienoyl (gamma-linolenoyl) respectively.


A phosphatidylcholine 34:3 in which the acyl groups specified at positions 1 and 2 are palmitoyl and (9Z,12Z,15Z)-octadecatrienoyl (alpha-linolenoyl) respectively.


A phosphatidylcholine 34:4 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (6Z,9Z,12Z,15Z)-octadecatetraenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine where the acyl groups at positions 1 and 2 are palmitoyl and icosanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoyl and (11Z)-eicosenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoyl and (11Z,14Z)-eicosadienoyl respectively.


A phosphatidylcholine 36:3 in which the acyl groups at positions 1 and 2 are specified as hexadecanoyl and (5Z,8Z,11Z)-icosatrienoyl respectively.


A phosphatidylcholine 36:3 in which the acyl group specified at positions 1 and 2 are hexadecanoyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.


A phosphatidylcholine 36:4 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 5Z,8Z,11Z,14Z-eicosatetraenoyl (arachidonoyl) respectively.


A phosphatidylcholine 36:5 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and docosanoyl respectively.


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (13Z)-docosenoyl respectively.


A  phosphatidylcholine 38:4  in which the acyl groups at positions 1 and 2 are hexadecanoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A phosphatidylcholine 38:5 in which the acyl groups at positions 1 and 2 are hexadecanoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A phosphatidylcholine 38:5 in which the acyl groups at positions 1 and 2 are hexadecanoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A phosphatidylcholine 38:6 in which the acyl groups at C-1 and C-2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are hexadecanoyl and (15Z)-tetracosenoyl respectively.


A phosphatidylcholine 30:2 in which the acyl groups specified at positions 1 and 2 are (9Z)-hexadecenoyl and (9Z)-tetradecenoyl respectively.


A phosphatidylcholine 16:0_16:1 in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and palmitoyl respectively.


A phosphatidylcholine 32:2 in which both phosphatidyl acyl groups are specified as palmitoleoyl.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and stearoyl respectively.


A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (9Z)-hexadecenoyl and (11Z)-octadecenoyl respectively.


A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as (9Z)-hexadecenoyl (palmitoleoyl) and (9Z)-octadecenoyl (oleoyl) respectively.


A phosphatidylcholine 34:3 in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and linoleoyl respectively.


A phosphatidylcholine 36:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-hexadecenoyl and (5Z,8Z,11Z,14Z)-eicosatetraenoyl respectively.


A phosphatidylcholine in which the acyl groups at C-1 and C-2 are (9Z)-hexadecenoyl and (13Z,16Z)-docosadienoyl respectively.


A phosphatidylcholine 32:0 in which the acyl group specified at positions 1 and 2 are stearoyl and myristoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1- and 2-acyl groups are specified as octadecanoyl and penttadecanoyl respectively.


A phosphatidylcholine 34:0 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and palmitoyl respectively.


A phosphatidylcholine 34:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (9Z)-hexadecenoyl respectively.


A phosphatidylcholine 36:0 in which both phosphatidyl acyl groups are specified as stearoyl (octadecanoyl).


A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-octadecenoyl respectively.


A phosphatidylcholine 36:1 in which the phosphatidyl acyl groups at positions 1 and 2 are stearoyl and oleoyl respectively.


A phosphatidylcholine 36:2 in which the acyl groups positions 1 and 2 are specified as octadecanoyl and (9Z,12Z)-octadecadienoyl respectively.


A phosphatidylcholine 36:3 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (6Z,9Z,12Z)-octadecatrienoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and alpha-linolenoyl respectively.


A phosphatidylcholine 36:4 in which the acyl groups at positions 1 and 2 are octadecanoyl and (6Z,9Z,12Z,15Z)-octadecatetraenoyl respectively.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and eicosanoyl respectively.


A phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-eicosenoyl respectively.


A phosphatidylcholine 36:3 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and (5Z,8Z,11Z)-icosatrienoyl respectively.


A  phosphatidylcholine 38:3 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.


A phosphatidylcholine 38:4 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A phosphatidylcholine 38:5 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (13Z)-docosenoyl respectively.


A phosphatidylcholine 40:4 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A phosphatidylcholine 40:5 in which the acyl groups at C-1 and C-2 are octadecanoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A phosphatidylcholine 40:5 inw hich teh acyl groups specified at positions 1 and 2 are octadecanoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A phosphatidylcholine 40:6 in which the acyl groups at positions  1 and 2 are octadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and tetracosanoyl respectively.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (15Z)-tetracosenoyl respectively.


A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and octadecanoyl respectively.


A 1,2-di-octadecenoylsn-glycero-3-phosphocholine in which the acyl group specified at positions 1 and 2 is 11Z)-octadecenoyl .


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and docosanoyl respectively.


A phosphatidylcholine 40:6 in which the acyl groups at C-1 and C-2 are (11Z)-octadecenoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A phosphatidylcholine 40:7 in which the acyl groups at C-1 and C-2 are (11Z)-octadecenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 32:1 in which the acyl groups specified at positions 1 and 2 are oleoyl and myristoyl respectively.


A phosphatidylcholine 34:1 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and palmitoyl respectively.


A phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (9Z)-hexadecenoyl respectively.


A phosphatidylcholine 36:1 in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and stearoyl respectively.


A  phosphatidylcholine 36:3 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and linoleoyl respectively.


A phosphatidylcholine 36:4 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (6Z,9Z,12Z)-octadecatrienoyl respectively.


A phosphatidylcholine 36:4  in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (9Z,12Z,15Z)-octadecatrienoyl respectively.


A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and eicosanoyl respectively.


A phosphatidylcholine 38:4 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (5Z,8Z,11Z)-eicosatrienoyl respectively.


A phosphatidylcholine 38:4 in which the acyl groups at positions 1 and 2 are specified as oleoyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


A phosphatidylcholine 38:5 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and arachidonoyl respectively.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and docosanoyl respectively.


A phosphatidylcholine 40:5 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A phosphatidylcholine 40:6 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A phosphatidylcholine 40:7 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and tetracosanoyl respectively.


A  phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and linoleoyl respectively.


A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and octadecanoyl respectively.


A 1,2-di-octadecadienoyl-sn-glycero-3-phosphocholine in which the double bonds in each fatty acyl group are at positions 9 and 12 and have Z configuration.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z)-octadecadienoyl and (5Z,8Z,11Z,14Z)-icosatetraenoyl respectively.


A  phosphatidylcholine 36:4 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z)-octadecatrienoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 42:4 in which the acyl groups specified at positions 1 and 2 are (6Z,9Z,12Z)-octadecatrienoyl and (15Z)-tetracosenoyl respectively.


A phosphatidylcholine 36:4 in which the acyl groups specified at positions 1 and 2 are (9Z,12Z,15Z)-octadecatrienoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 36:6 in which the acyl groups specified at positions 1 and 2 is (9Z,12Z,15Z)-octadecatrienoyl.


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as icosanoyl (arachidyl) and tetradecanoyl (myristoyl) respectively.


A phosphatidylcholine 36:0 where the acyl substituents at positions 1 and 2 are icosanoyl and palmitoyl respectively.


A phosphatidylcholine 38:0 in which the acyl groups at positions 1 and 2 are specified as eicosanoyl and octadecanoyl respectively.


A  phosphatidylcholine 38:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z)-octadecenoyl respectively.


A phosphatidylcholine 38:1 in which the acyl groups at positions 1 and 2 are eicosanoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 38:2 which carries an icosanoyl group at position 1 and a (6Z,9Z)-18-oxooctadeca-6,9-dien-18-yl group at position 2.


A phosphatidylcholine 40:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z)-eicosenoyl respectively.


A phosphatidylcholine 40:2 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z,14Z)-eicosadienoyl respectively.


A phosphatidylcholine 40:4 in which the two acyl substituents at positions 1 and 2 are specified as icosanoyl and arachidonoyl respectively.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and docosanoyl respectively.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (13Z)-docosenoyl respectively.


A phosphatidylcholine 42:5 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A phosphatidylcholine 42:6 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A phosphatidylcholine 40:2 in which the acyl group specified at positions 1 and 2 is (11Z)-eicosenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at position 1 and 2 are specified as arachidonoyl and palmitoyl respectively.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (5Z,8Z,11Z,14Z)-eicosatetraenoyl and (9Z,12Z)-octadecadienoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the phosphatidyl acyl groups at positions 1 and 2 are both arachidonoyl.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 36:0 in which the acyl groups specified at positions 1 and 2 are docosanoyl and tetradecanoyl respectively.


A phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are docosanoyl and hexadecanoyl respectively.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are docosanoyl and eicosanoyl respectively.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are docosanoyl and (11Z)-eicosenoyl respectively.


A phosphatidylcholine 40:4 in which the acyl groups specified at positions 1 and 2 are (7Z,10Z,13Z,16Z)-docosatetraenoyl and octadecanoyl respectively.


A phosphatidylcholine (22:4/20:4) which carries a (6Z,9Z,12Z,15Z)-22-oxodocosa-6,9,12,15-tetraen-22-yl group at position 1 and a (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl group at position 2.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and hexadecanoyl respectively.


A  phosphatidylcholine 38:0 in which the acyl groups specified at positions 1 and 2 are tetracosanoyl and tetradecanoyl respectively.


A phosphatidylcholine 42:0 in which the acyl groups specified at positions 1 and 2 are tetracosanoyl and octadecanoyl respectively.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are tetracosanoyl and (9Z)-octadecenoyl respectively.


Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester (9CI)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as tetradecanoyl and docosanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as pentadecanoyl and octadecanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as pentadecanoyl and docosanoyl respectively.


Hexadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester (9CI)


A phosphatidylethanolamine 32:1 in which the acyl groups at C-1 and C-2 are hexadecanoyl and (9Z)-hexadec-9-enoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 11Z-octadecenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl and icosanoyl respectively.


Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (R)-


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at C-1 and C-2 are hexadecanoyl and (13Z)-docosenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups specified at position 1 and 2 are palmitoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A phosphatidylethanolamine 36:1 zwitterion obtained by transfer of a proton from the amino to the phosphate group of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine.


Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester, (R)-


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as octadecanoyl and (7Z,10Z,13Z,16Z)-docosatetraenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as (11Z)-octadecenoyl and (13Z,16Z)-docosadienoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as (6Z,9Z,12Z,15Z)-octadecatetraenoyl and (15Z)-tetracosenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as icosanoyl (arachidoyl) and hexadecanoyl (palmitoyl) respectively.


Eicosanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxooctadecyl)oxy]propyl ester, (R)-


Docosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxoeicosyl)oxy]ethyl ester, (R)-


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as (11Z,14Z)-icosadienoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as docosanoyl and tetradecanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as docosanoyl and pentadecanoyl respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both the acyl groups specified is (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


Tetracosanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxoeicosyl)oxy]propyl ester, (R)-


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as octadecanoyl (stearoyl).


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as 9Z,12Z-octadecadienoyl (linoleoyl).


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as (5Z,8Z,11Z,14Z)-icosatetraenoyl (arachidonyl).


A 1-octadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl (arachidonoyl).


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as octadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


N-Palmitoyldihydrosphingomyelin

A sphingomyelin 34:0 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and sphinganine respectively.


N-Palmitoylsphingomyelin

A sphingomyelin 34:1 in which the N-acyl group and sphingoid base are specified as hexadecanoyl and sphingosine respectively.


11-epi-Prostaglandin F2alpha

The prostaglandin F that is the 11-epimer of prostaglandin F2alpha.


An oxoicosatetraenoic acid having a 5-oxo group; and (6E)-, (8Z), (11Z)- and (14Z)-double bonds.


1-Salicylate glucuronide

A beta-D-glucosiduronic acid that is the glucuronide conjugate of salicyclic acid.


Acetaminophen glucuronide

A beta-D-glucosiduronic acid that is the O-glucuronide of paracetamol (acetaminophen).


Ethyl glucuronide

A beta-D-glucosiduronic acid that is the ethyl derivative of beta-D-glucuronic acid.


glucocorticoid-remediable aldosteronism

Familial hyperaldosteronism type I (FH-I) is a rare heritable, glucocorticoid remediable form of primary aldosteronism (PA) characterized by early-onset hypertension, hyperaldosteronism, variable hypokalemia, low plasma renin activity (PRA), and abnormal production of 18-oxocortisol and 18-hydroxycortisol.


Octanoylglucuronide

A carboxylic ester resulting from the formal condensation of the carboxylic acid group of octanoic (caprylic) acid with the anomeric hydroxy group of beta-D-glucuronic acid.


Dehydroepiandrosterone 3-glucuronide

A steroid glucosiduronic acid having dehydroepiandrosterone as the steroid component.


17alpha-Estradiol 3-glucosiduronic acid

A steroid glucosiduronic acid that is 17alpha-estradiol having a single beta-D-glucuronic acid residue attached at position 3.


Mead acid

A 5,8,11-eicosatrienoic acid in which all three double bonds adopt cis-configuration.


A lysophosphatidylcholine 14:0 in which the acyl group specified is myristoyl. The major species at pH 7.3.


A lysophosphatidylcholine 14:1 in which the remaining acyl group is (9Z)-tetradecenoyl.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as pentadecanoyl.


A lysophosphatidylcholine 16:0 in which a hexadecanoyl (palmitoyl) group is attached to the glycero moiety at position 1.


A  1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (9Z)-hexadecenoyl (palmitoleoyl).


A lysophosphatidylcholine 18:0 in which the acyl substituent is located at position 1 and is specified as stearoyl.


A lysophosphatidylcholine 18:1 in which the acyl group specified as position 1 is (11Z)-octadecenoyl.


A lysophosphatidylcholine 18:2 in which the acyl group at position 1 is (9Z,12Z)-octadecadienoyl.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as icosanoyl.


A 1-icosenoyl-sn-glycero-3-phosphocholine in which the the double bond of the icosenoyl group is at the 11-12 position and has Z configuration.


A lysophosphatidylcholine 20:2 in which the acyl group is specified as (11Z,14Z)-icosadienoyl and is located at position 1.


A lysophosphatidylcholine 20:3 in which the acyl group at position 1 is (5Z,8Z,11Z)-icosatrienoyl (meadoyl) and the hydroxy group at position 2 is unsubstituted.


A lysophosphatidylcholine 20:3/0:0 in which the acyl group at position 1 is specified as (8Z,11Z,14Z)-icosatrienoyl.


A lysophosphatidylcholine 20:4 in which the acyl group at position 1 is (5Z,8Z,11Z,14Z)-icosatetraenoyl (arachidonoyl) and the hydroxy group at position 2 is unsubstituted.


A lysophosphatidylcholine 20:4 in which the the acyl group at position 1 is specified  as (8Z,11Z,14Z,17Z)-icosatetraenoyl.


A lysophosphatidylcholine 22:4 in which the acyl group is specified as (7Z,10Z,13Z,16Z)-docosatetraenoyl and is located at position 1.


A lysophosphatidylcholine 22:5 in which the acyl group at position 1 is (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl and the hydroxy group at position 2 is unsubstituted.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl.


A lysophosphatidylcholine 22:6 in which the remaining acyl group is (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl.


A lysophosphatidylcholine 24:0 in which the acyl group is specified as tetracosanoyl and is located at position 1.


A  lysophosphatidylcholine P-16:0 in which the alk-1-enyl group is hexadec-1-en-1-yl.


A 1-(Z)-alk-1-enyl-sn-glycero-3-phosphocholine in which the alkenyl group is (1Z,9Z)-octadecadienyl.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as hexadecanoyl (palmitoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (11Z)-octadec-9-enoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (9Z)-octadec-9-enoyl (oleoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which  acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as (9Z)-hexadec-9-enoyl (pamitoleoyl) and octadecanoyl (stearoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecanoyl (stearoyl) and hexadecanoyl (palmitoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecanoyl (stearoyl) and 9Z-octadecenoyl (oleoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) where the acyl groups at positions 1 and 2 are stearoyl and arachidonoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as (9Z)-octadec-9-enoyl (oleoyl) and hexadecanoyl (palmitoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as oleoyl.


Tetraoleoyl cardiolipin

A cardiolipin derivative in which all four of the phosphatidyl acyl groups are specified as oleoyl.


Tetralinoleoyl cardiolipin

A cardiolipin in which all four phosphatidyl acyl groups are specified as linoleoyl.


A ceramide 1-phosphate that is the N-dodecanoyl (lauroyl) derivative of sphingosine.


A monocarboxylic acid amide that is acetamide substituted by a phenyl group at position 2.


gamma-Glutamyl-Se-methylselenocysteine

A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of Se-methylselenocysteine.


2-Hexenoic acid, (2E)-

The (E)-stereoisomer of hexenoic acid.


Crotonic acid

A but-2-enoic acid with a trans- double bond at C-2. It has been isolated from Daucus carota.


3-Oxooctanoic acid

A derivative of octanoic acid carrying a beta-oxo group; a possible metabolite of 2-octynoic acid.


(R)-3-hydroxyoctanoic acid

The (R)-enantiomer of 3-hydroxyoctanoic acid; an important building block in the biomedical and pharmaceutical fields.


3-Oxodecanoic acid

An oxo fatty acid that is the 3-oxo derivative of decanoic acid.


2-Decenoic acid

A 2-decenoic acid having its double bond in the trans configuration. It is an intermediate metabolite in the fatty acid synthesis.


(3R)-3-Hydroxydodecanoic acid

The (R)-enantiomer of 3-hydroxylauric acid. An intermediate in fatty acid biosynthesis.


2-Dodecenoic acid

The trans isomer of 2-dodecenoic acid.


3-Oxotetradecanoic acid

A C14, long-chain fatty acid carrying an oxo- group at position 3.


(R)-3-Hydroxytetradecanoic acid

A 3-hydroxytetradecanoic acid that has R configuration at position 3. It plays an intermediate role in fatty acid biosynthesis.


2-Tetradecenoic acid

A 2-tetradecenoic acid having trans-configuration.


3-Oxohexadecanoic acid

An oxo-fatty acid comprising palmitic acid having an oxo group at the 3-position; an intermediate in fatty acid biosynthesis.


2-Hexadecenoic acid

A hexadecenoic acid having a trans-double bond at the 2-position.


A 1-methylxanthine tautomer where the imidazole proton is located at the 7-position.


1,7-Dimethyluric acid

An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-1 and N-7. It is a metabolite of caffeine and is often found in human urine samples.


An organoselenium compound that is adenylyl selenate with the hydroxy at position 3' replaced by a phosphate group.


An aminouracil that is D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminouracil. Early intermediate in bacterial riboflavin synthesis.


A lysophosphatidylcholine 18:0 in which the acyl group is specified as stearoyl (octadecanoyl) and is located at position 2.


A 1-acyl-sn-glycerol that has octadecanoyl (stearoyl) as the 1-acyl group.


allergic rhinitis, susceptibility to

An inherited susceptibility or predisposition to developing allergic rhinitis.


A HETE having a (5S)-hydroxy group and (6E)-, (8Z)-, (11Z)- and (14Z)-double bonds.